Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 167,445	$ 278,996	$ 238,114
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on sales of investment in unconsolidated joint ventures	(56,267)	(13,083)	(45,767)
Loss (gain) on investment property transactions	9	(152,547)	(90,125)
Impairment	0	0	14,829
Depreciation and amortization	295,587	288,092	288,648
Amortization of deferred financing costs and premium on notes payable	(99)	(437)	(888)
Equity-classified stock-based compensation expense, net of forfeitures	10,138	7,459	5,298
Effect of non-cash adjustments to rental revenues	(41,731)	(39,473)	(52,593)
Income from unconsolidated joint ventures	(7,700)	(6,801)	(7,947)
Operating distributions from unconsolidated joint ventures	5,399	11,542	9,303
Gain on extinguishment of debt	(169)	0	0
Changes in other operating assets and liabilities:
Change in receivables and other assets, net	1,723	5,500	(2,439)
Change in operating liabilities, net	(9,169)	10,230	(5,345)
Net cash provided by operating activities	365,166	389,478	351,088
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from investment property sales, net	0	555,333	435,833
Proceeds from sale of interest in unconsolidated joint ventures, net	38,831	67,066	53,601
Property acquisition, development, and tenant asset expenditures	(342,241)	(787,810)	(619,602)
Return of capital distributions from unconsolidated joint venture	16,805	39,422	2,151
Contributions to unconsolidated joint ventures	(47,894)	(65,077)	(4,285)
Change in notes receivable and other assets	0	0	(161)
Net cash used in investing activities	(334,499)	(191,066)	(132,463)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from credit facility	428,700	855,500	575,500
Repayment of credit facility	(600,600)	(859,400)	(594,600)
Proceeds from term loans	400,000	350,000	0
Repayment of term loans	0	(250,000)	0
Proceeds from mortgages	42,118	0	0
Repayment of mortgages	(168,401)	(109,469)	(38,700)
Payment of deferred financing costs	(8,231)	(2,989)	(73)
Issuance of common stock	103,120	0	0
Proceeds from sale of treasury stock	514	0	0
Common dividends paid	(192,275)	(182,840)	(176,263)
Contributions from noncontrolling interests	2,866	6,154	5,197
Distributions to noncontrolling interests	(114)	(1,338)	(1,156)
Acquisition of partner's noncontrolling interest	(43,387)	0	0
Net cash used in financing activities	(35,690)	(194,382)	(230,095)
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	(5,023)	4,030	(11,470)
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT BEGINNING OF PERIOD	10,168	6,138	17,608
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF PERIOD	$ 5,145	$ 10,168	$ 6,138